Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Becker Private Equity & Business Podcast

7 Stocks Taking it on the Chin 3-7-25

07 Mar 2025

1 min duration
414 words
1 speakers
07 Mar 2025
Description

In this episode, Scott Becker breaks down seven stocks that faced major losses this week, including Carvana, Marvell Technology, Palantir, and Netflix.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

Chapter 1: What are the seven stocks discussed in this episode?

0.203 - 19.944

This is Scott Becker with the Becker Private Equity and Business Podcast. Today's discussion is seven stocks that we watch closely, taking it on the chin. And I'll just walk through seven of these stocks pretty quickly. The first is Carvana. And I'm not an investor in most of these companies. I'm an investor in one of them. That one's not doing any better than the rest.

0

Chapter 2: Why did Carvana stock drop significantly?

Chapter 3: What challenges is Marvell Technology facing?

Chapter 4: What happened to Palantir's stock performance?

20.404 - 46.443

Carvana dropped 13.5% on Thursday. Had a tough, tough week. Always unsure if it's smoke and mirrors or a real company. Second, Marvel Technology in the semiconductor chip business dropped 20%, a disaster. Hims and Hers dropped 16% on Thursday. Palantir, a company we're investing in directly, I was the biggest fan of. One of my biggest winners is no longer that. It dropped 11%.

0

48.602 - 71.932

Netflix dropped also around 8%. So Netflix and chill, I guess. My portfolio is chilling. Tempest AI, the brilliant cancer oncology company, I company dropped 8%, 9%. And Peloton, and who uses the Peloton anymore, dropped again by about 9%. So it's a disaster in the market for those companies and many, many more. Thank you for listening to the Becker Private Equity and Business Podcast.

0

72.152 - 73.173

Thank you very, very much.

0
Comments

There are no comments yet.

Please log in to write the first comment.